99 related articles for article (PubMed ID: 8982666)
1. Effects of felbamate on veratridine- and K(+)-stimulated release of glutamate from mouse cortex.
Srinivasan J; Richens A; Davies JA
Eur J Pharmacol; 1996 Nov; 315(3):285-8. PubMed ID: 8982666
[TBL] [Abstract][Full Text] [Related]
2. The effect of the desglycinyl metabolite of remacemide hydrochloride (FPL 12495AA) and dizocilpine (MK-801) on endogenous amino acid release from mouse cortex.
Srinivasan J; Richens A; Davies JA
Br J Pharmacol; 1995 Dec; 116(8):3087-92. PubMed ID: 8719781
[TBL] [Abstract][Full Text] [Related]
3. Excitoprotective effect of felbamate in cultured cortical neurons.
Kanthasamy AG; Matsumoto RR; Gunasekar PG; Trunong DD
Brain Res; 1995 Dec; 705(1-2):97-104. PubMed ID: 8821739
[TBL] [Abstract][Full Text] [Related]
4. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
McCabe RT; Wasterlain CG; Kucharczyk N; Sofia RD; Vogel JR
J Pharmacol Exp Ther; 1993 Mar; 264(3):1248-52. PubMed ID: 8383742
[TBL] [Abstract][Full Text] [Related]
5. Felbamate modulates the strychnine-insensitive glycine receptor.
White HS; Harmsworth WL; Sofia RD; Wolf HH
Epilepsy Res; 1995 Jan; 20(1):41-8. PubMed ID: 7713059
[TBL] [Abstract][Full Text] [Related]
6. Donepezil attenuates excitotoxic damage induced by membrane depolarization of cortical neurons exposed to veratridine.
Akasofu S; Sawada K; Kosasa T; Hihara H; Ogura H; Akaike A
Eur J Pharmacol; 2008 Jul; 588(2-3):189-97. PubMed ID: 18508044
[TBL] [Abstract][Full Text] [Related]
7. Effects of bilobalide on amino acid release and electrophysiology of cortical slices.
Jones FA; Chatterjee SS; Davies JA
Amino Acids; 2002 Jun; 22(4):369-79. PubMed ID: 12107763
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Pharmacol Biochem Behav; 1996 Oct; 55(2):281-7. PubMed ID: 8951966
[TBL] [Abstract][Full Text] [Related]
9. Effects of felbamate, kynurenic acid derivatives and NMDA antagonists on in vitro kainate-induced epileptiform activity.
Domenici MR; Marinelli S; Sagratella S
Life Sci; 1996 May; 58(26):PL391-6. PubMed ID: 8691980
[TBL] [Abstract][Full Text] [Related]
10. Release of D-[3H]aspartic acid from the rat striatum. Effect of veratridine-evoked depolarization, fronto-parietal cortex ablation, and striatal lesions with kainic acid.
Arqueros L; Abarca J; Bustos G
Biochem Pharmacol; 1985 Apr; 34(8):1217-24. PubMed ID: 2581579
[TBL] [Abstract][Full Text] [Related]
11. Felbamate but not phenytoin or gabapentin reduces glutamate release by blocking presynaptic NMDA receptors in the entorhinal cortex.
Yang J; Wetterstrand C; Jones RS
Epilepsy Res; 2007 Dec; 77(2-3):157-64. PubMed ID: 17980555
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical studies with the anticonvulsant felbamate in mouse brain.
Fraser CM; Sills GJ; Forrest G; Thompson GG; Brodie MJ
Pharmacol Res; 1999 Sep; 40(3):257-61. PubMed ID: 10479470
[TBL] [Abstract][Full Text] [Related]
13. Felbamate block of the N-methyl-D-aspartate receptor.
Subramaniam S; Rho JM; Penix L; Donevan SD; Fielding RP; Rogawski MA
J Pharmacol Exp Ther; 1995 May; 273(2):878-86. PubMed ID: 7752093
[TBL] [Abstract][Full Text] [Related]
14. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182
[TBL] [Abstract][Full Text] [Related]
15. Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum.
Waldmeier PC; Martin P; Stöcklin K; Portet C; Schmutz M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):164-72. PubMed ID: 8857593
[TBL] [Abstract][Full Text] [Related]
16. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
[TBL] [Abstract][Full Text] [Related]
17. Felbamate inhibits cloned voltage-dependent Na+ channels from human and rat brain.
Taglialatela M; Ongini E; Brown AM; Di Renzo G; Annunziato L
Eur J Pharmacol; 1996 Dec; 316(2-3):373-7. PubMed ID: 8982710
[TBL] [Abstract][Full Text] [Related]
18. Felbamate increases [3H]glycine binding in rat brain and sections of human postmortem brain.
McCabe RT; Sofia RD; Layer RT; Leiner KA; Faull RL; Narang N; Wamsley JK
J Pharmacol Exp Ther; 1998 Aug; 286(2):991-9. PubMed ID: 9694960
[TBL] [Abstract][Full Text] [Related]
19. Felbamate displays in vitro antiepileptic effects as a broad spectrum excitatory amino acid receptor antagonist.
Domenici MR; Sagratella S; Ongini E; Longo R; Scotti de Carolis A
Eur J Pharmacol; 1994 Dec; 271(2-3):259-63. PubMed ID: 7705426
[TBL] [Abstract][Full Text] [Related]
20. Felbamate, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular Ca2+ concentration.
Taylor LA; McQuade RD; Tice MA
Eur J Pharmacol; 1995 Apr; 289(2):229-33. PubMed ID: 7621896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
